Predictive Acquisition Cost (PAC) is a drug pricing tool you can use to analyze loss files and make your GER agreements more stable to improve profits and performance. Read the eBook.
Two transformational multibillion-dollar deals in the healthcare and pharmacy industries have been in the works for months—the $69 billion CVS-Aetna merger and the $52 billion Cigna-Express Scripts merger—despite concerns that more consolidation will mean higher costs and fewer choices for patients.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%